Abstract:Highlights • Rosiglitazone and lobeglitazone are important building blocks. • Designed millireactors performed well the API syntheses. • Good performance was achieved by specific micromixer designs. • Efficient numbering-up was demonstrated. • Accurate flow rate control was achieved by the flow distributors. Microreactor Technology (MRT) appears as an interesting alternative for process intensification, including the development of continuous synthesis of fine chemicals and Active Pharmaceutical Ingredients (API). The inherent proposal of MRT is to reduce the scale-up time by simply increasing the number of microreactors in parallel, the numbering-up concept using optimal designed micro or millidevices. Among the API, rosiglitazone and lobeglitazone are derivatives of thiazolidine-2,4-dione (TZD), which is used as a building block, for molecules with biological activity, sensitive to insulin and, thus, with its administration the body makes better use of the insulin it produces, being an important structural element in medicinal chemistry, especially for type 2 diabetes mellitus, one of the biggest concerns in the health area worldwide, affecting nowadays more than 180 million people. The numerical assessment of MRT for various API synthesis related to type 2 diabetes mellitus drugs indicates its comparable or superior performance compared to traditional batch process. Specifically, proposed micromixer designs facilitate successful scale-up to milliscale while maintaining microscale performance, with significantly lower pressure drops than commercial Asia microreactors. The proposed flow distributors offer good performance in ensuring uniform distribution across outlets due to their conical shape design and laminar flow regime, with low pressure drops. The flow distributor with eights outlet is preferred for higher flow rates due to its superior performance, minimizing the pressure drops. Efficient flow rate and molar concentration control at each reactor unit can be ensured by using one distributor for each reactant's feed stream. This approach guarantees accurate concentration, flow rate control and ideal residence time, ultimately facilitating higher total throughput for scale-up. The potential use of micromixer actuators lies in its ability to maintain or enhance performance while transitioning from micro to milli-scale, offering promising alternatives for process intensification and scale-up in pharmaceutical synthesis, particularly for medications targeting type 2 diabetes mellitus. Graphical abstract Download : Download high-res image (163KB) Download : Download full-size image

Process intensification in flow chemistry using micro and millidevices: numerical simulations of the syntheses of three different intermediate API compounds for Diabetes Mellitus drug production

Smart scale-up of micromixers for efficient continuous biodiesel synthesis: A numerical study for process intensification

Micro reactor and flow chemistry for industrial applications in drug discovery and development

Scaling Up Microreactors for Kilogram‐scale Synthesis of Piperacillin: Experiments and Computational Fluid Dynamics Simulations

[Application of Continuous Mixing Technology in Ethanol Precipitation Process of Salvia Miltiorrhiza by Using Micromixer].

Biocatalytic Continuous Manufacturing of Diabetes Drug: Plantwide Process Modeling, Optimization, and Environmental and Economic Analysis

Bench-scale Microfluidic Manufacturing of Cross-linked Polyester Microparticles

Process intensification of pharmaceutical powder blending at commercial throughputs by utilizing semi-continuous mini-blending

A platform for automated nanomole-scale reaction screening and micromole-scale synthesis in flow

Automated Optimization of a Multistep, Multiphase Continuous Flow Process for Pharmaceutical Synthesis

A modular flow process intensification towards lipid peptoids nano assembly formation

Large-scale crystallization as an intermediate processing step in insulin downstream process: explored advantages and identified tool for process intensification

Multiphasic Continuous‐Flow Reactors for Handling Gaseous Reagents in Organic Synthesis: Enhancing Efficiency and Safety in Chemical Processes

Microfluidic nanoparticle synthesis for oral solid dosage forms: a step toward clinical transition processes

Establishment and Development of Organolithium-Mediated Continuous Flow Process for Intermediate of Canagliflozin

A Comprehensive Workflow towards More Equant‐Shaped Crystals of Active Pharmaceutical Ingredients

Easy-to-perform and cost-effective fabrication of continuous-flow reactors and their application for nanomaterials synthesis

On-demand Continuous-Flow Production of Pharmaceuticals in a Compact, Reconfigurable System.

Establishment of a semi-continuous nano-production line using the Microfluidizer® technology for the fabrication of lipid-based nanoparticles part 1: Screening of critical parameters and design of experiment optimization studies

Transitioning the production of lipidic mesophase-based delivery systems from lab-scale to robust industrial manufacturing following a risk-based quality by design approach augmented by artificial intelligence

Optimized design of macro‐microreactor for scale‐up of liquid–liquid chemical processes